Reunion Neuroscience Inc (REUN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,685 | -30,967 | -22,638 | -10,537 | -43,633 |
| Depreciation Amortization | 911 | 888 | 923 | 943 | 2,875 |
| Accounts receivable | 362 | -527 | -621 | -551 | -359 |
| Other Working Capital | 2,494 | 449 | -667 | 126 | -308 |
| Other Operating Activity | 11,799 | 12,834 | 8,375 | 1,632 | 6,113 |
| Operating Cash Flow | $-21,119 | $-17,323 | $-14,628 | $-8,387 | $-35,312 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 0 | 0 | -5,969 | -6,100 | 57,877 |
| PPE Investments | -175 | -171 | -178 | -44 | -2,378 |
| Purchase Of Investment | -7,419 | -7,231 | -7,515 | N/A | N/A |
| Purchase Sale Intangibles | -11 | -11 | -11 | -11 | -177 |
| Other Investing Activity | 1,841 | 2,061 | 2,112 | -11 | -514 |
| Investing Cash Flow | $-5,754 | $-5,341 | $-11,548 | $-6,155 | $54,985 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 16 |
| Common Stock Issued | 65 | 13 | 12 | 1 | 504 |
| Other Financing Activity | -678 | -661 | -687 | -337 | -732 |
| Financing Cash Flow | $-614 | $-648 | $-675 | $-337 | $-212 |
| Exchange Rate Effect | -337 | -363 | -386 | -410 | 200 |
| Beginning Cash Position | 48,792 | 47,553 | 49,417 | 50,507 | 31,794 |
| End Cash Position | 20,968 | 23,878 | 22,180 | 35,219 | 51,455 |
| Net Cash Flow | $-27,824 | $-23,675 | $-27,237 | $-15,288 | $19,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,119 | -17,323 | -14,628 | -8,387 | -35,312 |
| Capital Expenditure | -175 | -171 | -178 | -44 | -2,378 |
| Free Cash Flow | -21,295 | -17,494 | -14,806 | -8,431 | -37,690 |